Arizona Attorney General Kris Mayes is urging consumers to check their eligibility for compensation. The state has joined a nationwide $39.1 million settlement with pharmaceutical company Apotex, according to the Arizona Attorney General's Office.

Consumers who purchased certain generic drugs from May 2009 to December 2019 may be eligible for compensation through a settlement with Apotex. Arizona Attorney General Kris Mayes stated, "Arizonans deserve a prescription drug market that puts patients ahead of profits," and "this settlement ensures Apotex is held accountable for years of price manipulation and gives consumers an opportunity to be compensated." The settlement, involving all 50 states and territories, is moving forward in the U.S. District Court in Hartford. Apotex and Heritage Pharmaceuticals were accused of inflating drug prices and limiting competition. As part of the settlement, both companies will cooperate in ongoing litigation against other drug manufacturers. Consumers can check their eligibility by calling 1-866-290-0182 or visiting www.AGGenericDrugs.com, as reported by the Arizona Attorney General's Office.

An investigation reviewing over 20 million documents and millions of phone records has revealed alleged collusion in the pharmaceutical industry, with competitors forming alliances at gatherings like "girls nights out," golf outings, and frequent communication. Arizona and several other states have filed three antitrust complaints, including one against Teva Pharmaceuticals, accusing companies of price fixing and limiting competition—practices described by insiders as "playing nice in the sandbox" and being a "responsible competitor." States including Alaska, California, and Colorado are seeking to address these claims and ensure a more competitive prescription drug market, as stated by the Arizona Attorney General's Office.